23^rd International Conference on Diabetes, Nutrition, Obesity and Eating Disorders August 16-17, 2024 Melbourne, Australia

Dr. Weiqun (George) Wang did BS in Biochemistry (1983), at Nanjing University, China, Ph.D. in Animal Physiology & Biochemistry (1990) at Nanjing Agricultural University, China followed by Post-doc in Animal Science (1991-1992) from the Department of Animal Science, University of Hawaii. Presently he is a Professor in the Department of Human Nutrition, at Kansas State University.

Immunology, Mucosal immunity, Innate immunity, Microbiology, Infectious diseases, and Cancer biology and immunology.

Experienced Postdoctoral Researcher with a demonstrated history of working in the hospital & healthcare industry. Skilled in nanoparticle drug delivery, image-guided drug delivery, and cancer theranostics. Strong research professional with a Ph.D. focused in Pharmaceutical Sciences from the University of Kentucky

Cancer theranostics, Nanoparticle drug delivery, Image-guided drug delivery, Glioblastoma

International Medical Sciences Academy • Fellow – Royal Society of Medicine, London • Life member - Association of Physicians of India, Cardiological Society of India, Indian College of Interventional Cardiology, Indian Rheumatology Association, Indian Society of Nephrology, Asian Pacific Society of Nephrology. Indian Society of Haemodialysis, Delhi Society of Haematology, Association of Physicians of India – Delhi Chapter, Cardiological Society of India – Delhi Chapter, Indian Medical Association. • Member - Alumni of Association, Department of Nephrology, I.M.S., Banaras Hindu University; Member – National Kidney Foundation, USA; Long-term member – European Society of Endocrinology.

Association for Health in Middle Aged, an NGO, registered with the Registrar of Societies, Government of National Capital Region.

Professor Xingbin Yang is the Professor and Dean of the College of Food Engineering and Nutritional Science at Shaanxi Normal University, China. He is the director of the Shaanxi Engineering Laboratory for Food Green Processing and Safety Control, China, and also works as an academic head of the Key Laboratory of the Ministry of Education for Medicinal Resources and Natural Pharmaceutical Chemistry, China. Professor Xingbin Yang received his doctoral degree in Pharmacology from the Fourth Military Medical University of China in 2004 and also spent about 2 years at the School of Medicine and Pharmacology, at the University of Western Australia, where he as a visiting professor cooperatively conducted clinical intervention trials in food vascular nutrition and evaluated the biological effects of vegetable nitrate/nitrite and dietary flavonoids. Currently, his group is investigating the mechanism of food metabolic toxicity and nutrition imbalance in vascular disorders, oncogenesis, fatty liver, and other metabolic diseases, as well as the nutritional regulation mechanism of several classes of bioactive functional carbohydrates and flavonoids. Another important emphasis of Dr. Yang’s research is on enhancing the health-promoting efficacy of bioactive food ingredients by improving their bioavailability. Dr. Yang’s group is also working on the interactions between the gut microbiome and diet structure and their roles in vascular health promotion. He has edited 5 books, filed 4 patents, and published over 70 papers in peer-reviewed journals.

Nutritional Biochemistry, Functional Foods with a specific interest in the Development of Diet-based Strategies for Disease Prevention and Health Promotion, Functional Foods and Nutraceuticals from plants

Professor Holt was the Editor-in-Chief of Diabetic Medicine (2016-2020) and is a past-Chair of the Council of Health Care Professionals of Diabetes UK. Professor Holt was a member of the 2008 NICE diabetes and pregnancy guideline development group and the NICE Type 2 diabetes: preventing the progression from pre-diabetes programme development group. Professor Holt is the Editor-in-Chief of the 5th edition of the Textbook of Diabetes. Professor Holt is Vice-Chair of the European Association for the Study of Diabetes (EASD) Committe for Clinical Affairs and was the EASD co-chair of the EASD-ADA consensus report of the management of type 1 diabetes in adults.

Professor Holt’s current research interests are broadly focussed around clinical diabetes but specifically encompass studies of the relationship between mental illness and diabetes and, diabetes and pregnancy. His clinical responsibilities include the diabetes and pregnancy clinic, young adult diabetes clinic and the cystic fibrosis related diabetes service.

The research program of K Sreekumaran Nair, M.D., Ph.D., has focused on the role of energy metabolism and the importance of altered protein turnover in diabetes and aging. Energy metabolism studies are performed mainly in mitochondria isolated from skeletal muscle biopsy samples. Specific methods include mitochondrial respiration, adenosine triphosphate (ATP) production rates, oxidant production, mitochondrial DNA abundance and mutations.

Dr. Nair's research team also investigates the impact of various interventions of the regulation of mitochondrial biogenesis. Analytical methods such as mass spectrometry and nuclear magnetic resonance spectroscopy allow the team to study metabolic consequences of altered energy and protein metabolism. Much of the team's work involves the use of stable isotope tracers to label proteins in vivo and study synthesis and accumulation of individual proteins. Post-translational modifications, especially carbonylation and deamidation, also are studied by mass spectrometry.

Dr Price has been recognised for her significant contribution to diabetes research, having expanded her team and attracted a large amount of commercially sponsored research to the Wessex region, which covers Dorset, Hampshire, South Wiltshire and the Isle of Wight. Her work has meant that participants are receiving cutting edge diabetes care from a team of expert researchers in the field. Hermione is joint training programme director for Diabetes and Endocrinology in Wessex and joint diabetes lead at Wessex NIHR Clinical Research Network. Hermione is a past lead for diabetes at the Wessex cardiovascular strategic clinical network. Hermione is an active researcher and is currently supervising several PhD students. Hermione works less than full time and is passionate about work/life balance and actively embraces the portfolio career.

Hermione is, amongst other things, a consultant diabetologist at Southern Health NHS Foundation Trust and University Hospitals Dorset. Her clinical interests include the management of diabetes and obesity in people living with severe and enduring mental illness.

I am a clinician scientist who combines research in diabetes with work as a consultant physician in the Royal Devon University Healthcare NHS Trust. My research interests are in precision approaches to the management of diabetes, with a focus on practical approaches that can impact clinical practice now or in the near future. This includes approaches to improving clinical classification of diabetes, both through optimising use of classification biomarkers such as C-peptide and islet autoantibodies, and through development of prediction models to combine clinical features and biomarkers to guide diabetes classification and treatment. This work has informed national and international guidance in this area. Additional interests include developing stratified approaches to treatment of type 2 diabetes and, as part of my work with the University of Exeter NIHR Global Health Group, approaches to effective diabetes diagnosis, monitoring and classification in low resource settings.

I have worked with colleagues in Exeter to develop practical inexpensive approaches to measuring insulin secretion using a test called C-peptide, and show that these approaches can be used to assist classification and treatment of diabetes. Our work in this area, together with our related work demonstrating that misclassification of diabetes is common, has contributed to the widespread up-take of C-peptide testing in clinical care to confirm diabetes subtype and treatment requirements.

Dr. Weiqun (George) Wang did BS in Biochemistry (1983), at Nanjing University, China, Ph.D. in Animal Physiology & Biochemistry (1990) at Nanjing Agricultural University, China followed by Post-doc in Animal Science (1991-1992) from the Department of Animal Science, University of Hawaii. Presently he is a Professor in the Department of Human Nutrition, at Kansas State University.

Food Safety and Molecular Diagnostics